Alnylam Pharmaceuticals reported $187.63M in Sales Revenues for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Sales Change
Acadia Pharmaceuticals ACAD:US $ 131.61M 16.39M
Alexion Pharmaceuticals ALXN:US $ 1636.5M 44.7M
Alnylam Pharmaceuticals ALNY:US $ 187.63M 32.92M
Amgen AMGN:US $ 6706M 180M
Arena Pharmaceuticals ARNA:US $ 0M 0M
Arrowhead Research ARWR:US $ 38.28M 7.61M
Biocryst Pharmaceuticals BCRX:US $ 40.99M 8.96M
Biomarin Pharmaceutical BMRN:US $ 408.74M 92.95M
Bluebird Bio BLUE:US $ 22.68M 15.2M
Dicerna Pharmaceuticals DRNA:US $ 62.95M 21.62M
Gw Pharmaceuticals GWPH:US $ 152.47M 4.24M
Intercept Pharmaceuticals ICPT:US $ 92.83M 3.75M
IONIS PHARMACEUT IONS:US $ 133M 7.25M
Mirati Therapeutics MRTX:US $ 71.79M 71.79M
Moderna Inc MRNA:US 4.97B 615M
Neurocrine Biosciences NBIX:US $ 296M 7.1M
Novartis NVS:US $ 13367M 73M
Ptc Therapeutics PTCT:US $ 138.74M 22.07M
Regeneron Pharmaceuticals REGN:US $ 3452.8M 1685.7M
Regulus Therapeutics RGLS:US $ 0M 0M
Sangamo Biosciences SGMO:US $ 28.56M 0.69M
Sarepta Therapeutics SRPT:US $ 189.41M 25.32M
Takeda 4502:JP Y 844820M 104783M
Ultragenyx Pharmaceutical RARE:US $ 81.65M 5.33M
Vertex Pharmaceuticals VRTX:US $ 1984.16M 190.79M
Xencor XNCR:US $ 19.68M 47.76M
YTE INCY:US $ 812.99M 107.28M